The case for a National Histopathology Service for organ retrieval and transplantation. Philip Whatling On behalf of NHA Team & audit champions.

Slides:



Advertisements
Similar presentations
Areas of Research Specific issues. Clinical Trials Phase I First use in humans of an experimental drug or treatment In a small group of healthy volunteers.
Advertisements

L. Szabo P. Laftsidis E. Ablorsu Cardiff Transplant Unit Cardiff UK HYPOTHERMIC MACHINE PERFUSION IMPROVES OUTCOMES IN DCD KIDNEYS.
The usual suspects: Barriers to access and its impact on SAM treatment coverage Jose Luis Alvarez Moran CMN project Coordinator London, UK October 18 th.
CRUISE LINE TOURISM STEERING COMMITTEE MEETING OUTCOMES OF THE WORKSHOP & PROGRESS 24 TH MARCH 2009.
Implementation of new technologies Dr Keith Cooper Southampton Health Technology Assessments Centre University of Southampton.
Draft Guidance for Industry: Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob.
Agreeing to the terms of audit engagement and management representations ISAs (UK and Ireland) 210 and 580 Martyn Jones November 2009.
Effects of Humoral Antibodies in Organ Transplantation: Boon or Bane? Reference: Ponticelli C. Humoral antibodies in organ transplantation: Angels or demons?
Directorate of Donor Care UK Transplant NHSBT Strategic Plan and ODTF Recommendations Regional Managers.
A Review of Referrals for Suspected Testicular Malignancy Mr Jonathan Harikrishnan ST3 Urology.
National Comparative Audit of Blood Transfusion National Blood Service UK Comparative Audit of Upper Gastrointestinal Bleeding and the Use of Blood Prepared.
Donor Organ Selection Criteria: What is Ideal? A Consensus (?) Discussion.
Organ Donation and Transplantation Strategic Performance Update Sally Johnson 26 March 2015.
ODT Workforce Design Project Midlands Regional Collaborative 2 nd December 2014 Ella Poppitt, Head of Service Design Organ Donation and Transplantation.
Horizon Scanning on organ perfusion
Regional Transplant Forum Sept Current national format NHSBT Kidney Advisory Group Renal Transplant Clinical Reference Group NHS England BTS Guidelines.
Our Focus On Benefits Realisation >> Delivering Accelerated and Sustainable Business Benefits An introduction to our Project Definition & Benefits Templates.
Reconditioning Donor Lungs for Transplantation Andrew Fisher
Student Fitness to Practise
Harefield DCD heart transplant programme
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Specialised Commissioning of Kidney Transplantation Keith Rigg Chair, Renal Transplant CRG.
The Role of Coordinators Throughout the European Union Carl-Ludwig Fischer-Fröhlich, Stuttgart, Germany Thank you to the support of support of all coordinators.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
Taskforce Implementation – Progress and Results Chris Rudge FRCS National Clinical Director for Transplantation Renal CDs Meeting 12 March 2010.
Review of DCD allocation scheme: the first 6 months Lisa Bradbury Statistics and Clinical Studies Renal Transplant Services Meeting 2015.
Allocation of elderly deceased donor kidneys Lisa Bradbury, Niaz Ahmad, Paul Gibbs, Richard Baker, Adam McLean, Chris Callaghan Renal Transplant Services.
“NHSBT strategic vision meeting” Dr. Les Russell - October Tel +44 (0) Confidential to OrganOx.
Background The renewed interest in DCD started since the 1990s following the persistent organ shortage from donation after brain death (DBD) and the short-
Providing the evidence…..linking social care, housing support and health data Gillian Barclay & Ellen Lynch Scottish Government.
PET/CT AND PAEDIATRIC ONCOLOGY: A SINGLE CENTRE EXPERIENCE A. Cistaro 1, L. Gastaldo 2, A. Brach del Prever 3, V. Arena 1, E. Pelosi 1, M. Mancini 1 CONCLUSIONS.
Organ Donation and Transplantation in Paediatrics.
May 2001 Management of Thyroid Cancer Information Projects Team THE MANAGEMENT OF PATIENTS WITH THYROID CANCER Cathy Bennett Information Projects Manager.
Liver Transplantation
1 The role of competent authorities in Bio Vigilance M. Jesus Felix Medical Coordinator of Tissues and Cells Catalan Transplant.
Implementing pre-transplant performance review by the Membership and Professional Standards Committee Membership & Professional Standards Committee Fall.
OPTN Liver and Intestinal Organ Transplantation Committee Update Spring 2012 Kim Olthoff, MD, Chair David Mulligan, MD, Vice-chair.
RISK FACTORS IN CADAVERIC DONORS OF LIVERS PROCURED FOR ELECTIVE AND URGENT RECIPIENTS Edyta Karpeta 1, Jarosław Czerwiński 2,3, Dariusz Wasiak 2, Piotr.
CARATTERIZZAZIONE DI LESIONI DI ORIGINE SCONOSCIUTA SOSPETTE PER LESIONI MALIGNE NEI PAZIENTI PEDIATRICI: POSSIBILE RUOLO DEL 18F-FDG PET/CT A.Cistaro.
Day-case medical thoracoscopy
Mission Development in Charges “Supporting growth in our churches” Diocese of Edinburgh St Hilda’s Fund.
Access to renal transplantation Chris Dudley UKRR/UKT Joint analysis.
Monday, June 23, 2008Slide 1 KSU Females prospective on Maternity Services in PHC Maternity Services in Primary Health Care Centers : The Females Perception.
Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function R3 김동연 /Prof. 정경환 N Engl J Med 373;5 July 30, 2015.
ACUTE APPENDICITIS IN PREGNANCY : HOW TO MANAGE? HAMRI.A, AARAB.M,NARJIS.Y, RABBANI.K, LOUZI.A,BENELKHAIAT.R, FINECH.B SERVICE DE CHIRURGIE DIGESTIVE MARRAKECH.
Key performance indicators (KPIs) for deceased donor kidney retrieval Chris Callaghan On behalf of Working Group 3, NORS Review Implementation Board Renal.
Can we improve deceased donor kidney utilisation? Chris Callaghan National Clinical Lead for Abdominal Organ Utilisation, NHSBT Consultant Transplant Surgeon,
NICE Quality Standard 48: Depression in children and young people An audit of adherence to Quality Standards within Camhs Dr. Angela Brennan Principal.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
Organ Donation Past, Present and Future Donation after Brain-Stem Death DBD Dr Farrel Igielman Dr Dale Gardiner Dr Gerlinde Mandersloot 4 th June 2013.
National Histopathology Service for Transplantation
Do trainers think their new dental trainees are prepared for practice? Method: Online questionnaires were sent to all Dental Foundation Trainers (n=667)
Living donation review Renal Transplant Services Meeting 17 March 2016 Aisling Courtney.
P Ferguson, R Hills, A Grech, L Kjeldsen, M Dennis, P Vyas, R Clark, N Russell, C Craddock, On behalf of the NCRI AML Working Group. An operational definition.
Transforming the organ donation and transplantation pathway Making it Safer, Simpler, Supportive with the Hub Programme Anne Sheldon – Head of Referral.
Strategies to increase transplantation
Kidney Transplantation.
Enterprise | Interest Nothing to disclose.
Organ Utilisation Strategy
Donation after Brain-Stem Death DBD
T. Rana, L. Szabo, A. Asderakis, E. Ablorsu
بسم الله الرحمن الرحيم.
John Grant-Casey & Sarah Hearnshaw
Organ Donation Update - GICU
Internal Audit Training
The BAHNO Head & Neck Cancer Surveillance Audit 2018
The BAHNO Head & Neck Cancer Surveillance Audit 2018
Penny Fletcher MSc MRPharmS IPresc
Midlands Organ Donation Services Team
Presentation transcript:

The case for a National Histopathology Service for organ retrieval and transplantation. Philip Whatling On behalf of NHA Team & audit champions

Introduction Unexpected lesions that require further characterisation may be identified during organ retrieval or at examination of the organ in the transplant centre. Further assessment of donor organ quality may also be required. Histopathological analysis may therefore become necessary at time of retrieval or before safe transplantation may proceed. No formal process in the UK for obtaining ‘out-of-hours’ histopathological report of retrieved organs

Introduction Histopathological report may become necessary when: a)A lesion suspicious for malignancy is identified – Type I b)Further assessment of organ quality is required – Type II It is unknown whether urgent histopathological analysis enables the utilisation of donor organs that would otherwise have been discarded.

The National Histopathology Audit Define current incidence of ‘urgent*’ histopathological analysis requests. Define numbers of retrieved organs utilised following histology. Identify impact of an out-of-hours histopathology service on: – Donor/organ utilisation – Recipient safety  Urgent biopsies were defined as those biopsies were the report was awaited in order to proceed either for retrieval or for transplantation.

Methods Prospective data collection 1 st October 2013 and 31 st March 2014 (6mo) All NORS team retrievals All Transplant Centres.

Results 100% Data Return 654 Retrievals 2322 Organs Retrieved – Utilised: 2064 (88%) – Taken, Accepted and Not Utilised: 258 (12%)

Results - Incidence 142 urgent biopsies in 654 retrievals (21.7%) – 42 Type 1 Biopsies (29.6%) – 100 Type 2 Biopsies (70.4%) 51% out-of-hours (1900 to 0700 and weekends)

Results - Incidence 95% biopsies sent to pathology services at NORS centres The organs biopsied at Transplant Centres were mostly Livers and Kidneys There was only one biopsy taken at CT Transplant Centre No biopsies from Pancreases

Results – biopsy incidence by age

Results – biopsy incidence by donor type 56% Biopsies were performed on DBD organs 44% Biopsies were performed on DCD organs

Results – Type 1 Biopsy 42/654 Biopsies for suspected malignancy (6.4%) 3/654 Malignancies identified (0.45%) 3/42 Biopsies confirmed malignancy (7%) There were 119 organs safely transplanted thanks to negative Bx report

Results – Type 2 Biopsy 100 Type 2 Biopsies – 22 liver – 78 kidney Unsuitable organ quality in 5% (4 kidneys;1 liver) 21 Livers and 74 Kidneys utilised following Type 2 Biopsy

Results – Organ specific (kidney) Age group: – 28/480 Not Utilised – 452/480 Utilised 32 Type 1 Biopsies 18 Type 2 Biopsies >60 Age group: – 59/465 Not Utilised – 406/465 Utilised 27 Type 1 Biopsies 52 Type 2 Biopsies Kidney Transplants proceeded on a background of biopsy

Results – Organ specific (liver) Age group: – 14/197 Not Utilised – 183/480 Utilised 9 Type 1 Biopsies 11 Type 2 Biopsies >60 Age group: – 30/165 Not Utilised – 135/465 Utilised 10 Type 1 Biopsies 23 Type 2 Biopsies Liver Transplants proceeded on a background of biopsy

Discussion – key points First data collected on national use of histopathology service for transplantation. Significant use of histopathology during audit period Older donors trigger biopsies Mostly type 2 biopsies Potentially significant decrease in inappropriate non-utilisation of organs?

Discussion – future questions National Retrieval Group has constituted a steering group – How significant is the role of an accessible national pathology service in increasing organ utilisation? Pilot Further evidence Service evaluation/development Logistics – Does such a service translate into improved graft/patient outcomes? Prospective study linked to the service evaluation project Retrospective analysis on biopsies already available

Acknowledgements NHA Team: Sarah Jones, Andrew Rayner, Ahmed Ali, Chris Callaghan, Rajesh Sivaprakasam and Roberto Cacciola Audit Champions: Gavin Pettigrew, Magdi Attia, Wayel Jassem, Hynek Mergental, Elijah Ablorsu, Majid Mukadam, Habib Kashi, Karen Stevenson, Yarwood Gemma, Pissanou Theodora, Nikhil Patil, Mr Al Attar, Bimbi Fernando, Roufosse, Candice, Mohammed Morsy, Gourab Sen, Katie McGoohan, Fletcher Nicholas, Tanveer Butt, Ali Machaal, Mehra Sanjay, Simon Boyes, Andrew Sutherland, Kourosh Saeb-Parsy, Catherine Sudarshan, Amanda Knight, Rajesh Sivaprakasam, Rajinder Singh, Srinivasan Parthi, Callaghan Christopher, Graetz Keith, Linda Boorer, Omar, Mohie, Nick Inston